Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of KOPRAN.. For more details, see the KOPRAN. quarterly results and KOPRAN. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.3 |
No. of shares | m | 48.21 |
1 Week | % | -6.1 |
1 Month | % | -15.0 |
1 Year | % | 56.5 |
52 week H/L | Rs | 292.4/140.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
KOPRAN. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 75 | 46 | 146 | 369 | 327 | |
Low | Rs | 33 | 16 | 22 | 105 | 96 | |
Sales per share (Unadj.) | Rs | 82.8 | 83.1 | 113.7 | 99.1 | 114.3 | |
Earnings per share (Unadj.) | Rs | 5.6 | 4.9 | 14.2 | 12.7 | 5.6 | |
Diluted earnings per share | Rs | 5.0 | 4.4 | 12.8 | 12.7 | 5.6 | |
Cash flow per share (Unadj.) | Rs | 7.6 | 7.1 | 16.6 | 15.0 | 8.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 1.50 | 3.00 | 3.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 1.35 | 3.00 | 3.00 | |
Avg Dividend yield | % | 0 | 0 | 1.8 | 1.3 | 1.4 | |
Book value per share (Unadj.) | Rs | 39.0 | 43.9 | 56.7 | 88.4 | 91.1 | |
Adj. book value per share | Rs | 34.9 | 39.3 | 50.8 | 88.4 | 91.1 | |
Shares outstanding (eoy) | m | 43.25 | 43.25 | 43.25 | 48.21 | 48.21 | |
Price / Sales ratio | x | 0.6 | 0.4 | 0.7 | 2.4 | 1.9 | |
Avg P/E ratio | x | 9.7 | 6.4 | 5.9 | 18.7 | 37.5 | |
P/CF ratio (eoy) | x | 7.1 | 4.4 | 5.1 | 15.9 | 25.5 | |
Price / Book Value ratio | x | 1.4 | 0.7 | 1.5 | 2.7 | 2.3 | |
Dividend payout | % | 0 | 0 | 10.5 | 23.7 | 53.1 | |
Avg Mkt Cap | Rs m | 2,323 | 1,346 | 3,634 | 11,434 | 10,205 | |
Total wages/salary | Rs m | 371 | 369 | 372 | 433 | 499 |
KOPRAN. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,579 | 3,595 | 4,918 | 4,775 | 5,510 | |
Other income | Rs m | 40 | 6 | 182 | 108 | 31 | |
Total revenues | Rs m | 3,619 | 3,601 | 5,100 | 4,883 | 5,541 | |
Gross profit | Rs m | 454 | 461 | 816 | 872 | 518 | |
Depreciation | Rs m | 87 | 96 | 102 | 111 | 127 | |
Interest | Rs m | 90 | 89 | 62 | 51 | 61 | |
Profit before tax | Rs m | 317 | 283 | 833 | 818 | 361 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 76 | 73 | 217 | 208 | 88 | |
Profit after tax | Rs m | 240 | 210 | 616 | 610 | 272 | |
Gross profit margin | % | 12.7 | 12.8 | 16.6 | 18.3 | 9.4 | |
Effective tax rate | % | 24.1 | 25.7 | 26.1 | 25.4 | 24.5 | |
Net profit margin | % | 6.7 | 5.8 | 12.5 | 12.8 | 4.9 |
KOPRAN. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,076 | 2,226 | 2,769 | 4,149 | 3,991 | |
Current liabilities | Rs m | 1,347 | 1,401 | 1,607 | 1,516 | 1,770 | |
Net working cap to sales | % | 20.4 | 23.0 | 23.6 | 55.1 | 40.3 | |
Current ratio | x | 1.5 | 1.6 | 1.7 | 2.7 | 2.3 | |
Inventory Days | Days | 5 | 6 | 5 | 7 | 11 | |
Debtors Days | Days | 884 | 942 | 891 | 974 | 1,077 | |
Net fixed assets | Rs m | 1,418 | 1,476 | 1,624 | 1,960 | 2,506 | |
Share capital | Rs m | 432 | 432 | 433 | 482 | 482 | |
"Free" reserves | Rs m | 1,252 | 1,464 | 2,018 | 3,780 | 3,910 | |
Net worth | Rs m | 1,685 | 1,897 | 2,450 | 4,262 | 4,392 | |
Long term debt | Rs m | 411 | 318 | 212 | 188 | 179 | |
Total assets | Rs m | 3,494 | 3,702 | 4,394 | 6,109 | 6,497 | |
Interest coverage | x | 4.5 | 4.2 | 14.4 | 17.0 | 6.9 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.1 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 1.0 | 1.1 | 0.8 | 0.8 | |
Return on assets | % | 9.4 | 8.1 | 15.4 | 10.8 | 5.1 | |
Return on equity | % | 14.3 | 11.1 | 25.1 | 14.3 | 6.2 | |
Return on capital | % | 19.4 | 16.8 | 33.6 | 19.5 | 9.2 | |
Exports to sales | % | 46.6 | 44.0 | 40.5 | 40.8 | 44.7 | |
Imports to sales | % | 8.2 | 9.2 | 6.5 | 3.0 | 10.1 | |
Exports (fob) | Rs m | 1,669 | 1,581 | 1,990 | 1,949 | 2,464 | |
Imports (cif) | Rs m | 294 | 332 | 321 | 144 | 558 | |
Fx inflow | Rs m | 1,669 | 1,581 | 1,990 | 1,949 | 2,464 | |
Fx outflow | Rs m | 364 | 397 | 374 | 208 | 624 | |
Net fx | Rs m | 1,304 | 1,184 | 1,617 | 1,741 | 1,840 |
KOPRAN. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 254 | 310 | 600 | -335 | 340 | |
From Investments | Rs m | -249 | -125 | -253 | -844 | -127 | |
From Financial Activity | Rs m | -6 | -181 | -346 | 1,228 | -198 | |
Net Cashflow | Rs m | -0 | 4 | 1 | 49 | 15 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Susheel G Somani | COMP SEC: Sunil Sodhani | YEAR OF INC: 1958 | BSE CODE: 524280 | FV (Rs): 10 | DIV YIELD (%): 1.3 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare KOPRAN. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.